pharmexec.com
/1 week ago
Latest updates for Biopharma
Fresh curated links around BioPharma are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
- <![CDATA[Roundup: Alteogen Enters Option & License Agreement with Novartis, NewBiologix & Synastra Form BioTe
- <![CDATA[The Status of Nuvation Bio’s Pipeline]]>
- Indiana Emerges as a Leading U.S. Biopharma Hub
Post angles to try
Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Fresh articles and ideas
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
genengnews.com
/4 weeks ago
Indiana Emerges as a Leading U.S. Biopharma Hub
Indiana has spent decades becoming a national leader in life sciences and pharmaceutical exports. Its strengths extend across universities, research institutes, manufacturers, supp...
genengnews.com
/2 weeks ago
In Massachusetts, Latest Annual Snapshot Shows a Tale of Two Biopharmas
The job contraction, according to MassBio, reflected pipeline reprioritization by biopharma giants plus contraction by smaller companies, with R&D jobs dropping significantly b...
pharmexec.com
/1 week ago
<
genengnews.com
/3 weeks ago
Biopharma’s Drawdown Is a Chance to Build Biotech Back Better
American biotechnology hubs like Boston, Seattle, and San Diego are starting to wake up again. But will they be able to learn from the lessons of the recent past? The post Biopharm...
pharmexec.com
/1 month ago
<
pharmexec.com
/5 days ago
<![CDATA[Your Questions Answered: The Biggest Pharma and Biotech Stories This Week]]>
pharmexec.com
/3 weeks ago
<
pharmexec.com
/1 month ago
<![CDATA[CSPC Pharmaceutical & AstraZeneca Form Joint Venture for Biologics Manufacturing in China]]>
pharmexec.com
/1 month ago
<![CDATA[Why Biologics R&D Platforms Are Failing Complex Modalities and What Must Change]]>
pharmexec.com
/1 month ago
<![CDATA[What FDA's Peptide Decision Means for the Industry]]>
fiercebiotech.com
/3 weeks ago
New Biotech-Academia Partnership Approaches to Empower the Drug Development Ecosystem
Addressing shifts in the global clinical development ecosystem and how academia and biotech can better partner to develop new therapies for patients.
fiercebiotech.com
/3 weeks ago
How Pharma Teams Evaluate Biotech Companies for Partnerships and Acquisitions
Addressing how interactions around partnerships or acquisitions differ from those of investment from biotech companies and how CMOs can support those conversations.
pharmexec.com
/1 week ago
<![CDATA[Pharmaceutical Executive Daily: DualityBio and Teva Strike Major Biopharma Deals]]>
pharmexec.com
/1 month ago
<![CDATA[Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals ]]>
pharmexec.com
/2 weeks ago
<![CDATA[What Executives and Investors Are Looking for in Pharma Companies]]>
pharmexec.com
/3 weeks ago
<![CDATA[Two Decades of Technology Transformation in Pharma]]>
pharmexec.com
/1 month ago
<![CDATA[argenx Acquires Forte Biosciences for $2.2 Billion]]>
pharmexec.com
/4 weeks ago
<![CDATA[U.S. Rare Disease Biotech Investing Rises After FDA’s PRV Program Renewal: Report ]]>
Turn fresh research into a full content calendar
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.
Sources covering Biopharma
feeds.feedburner.com
Recent coverage from public sources
Public source
seekingalpha.com
Recent coverage from public sources
Public source
fiercebiotech.com
Recent coverage from public sources
Public source
pharmexec.com
Recent coverage from public sources
Public source